Oracle buys desktop software virtualiser GreenBytes

Gets better-than ZFS dedupe


Oracle is buying desktop software virtualiser GreenBytes, which uses ZFS technology, for an undisclosed sum.

GreenBytes VDI software is based on ZFS and includes its own, highly rated deduplication engine and replication. It can run on flash hardware and, originally, GreenBytes sold a VDI flash appliance but got out if hardware in August last year. It was founded in 2007 by Bob Petrocelli, its current CEO, and Richard Petrocelli, a director, and took in some $37m in GreenBytes’s exec-contributed and VC funding.

That suggests that, unless the company was distressed, the backers could have a received an up to 4X - 5X payout, meaning $150 - $185m - that sounds a lot of cash for a SW-only VDI supplier, especially with Atlantis making waves in the market, and hybrid array makers like Nimble, Tegile and Tintri pushing VDI hard.

We haven’t had any recent announcements from GreenBytes about its business progress and so cannot tell if it was doing well or badly. There might be some distress here which would reduce the amount of cash or shares that Oracle paid.

The deal announcement said GreenBytes’ technology ”is expected to enhance Oracle's ZFS Storage Appliances, and that could mean the ZFS appliance getting GreenBytes’ deduplication engine. Oracle said it “is currently reviewing the existing GreenBytes product roadmap” and will be providing guidance to customers at some point.

The deal is expected to close by the mid-year point. ®

Similar topics

Broader topics

Narrower topics


Other stories you might like

  • Google sours on legacy G Suite freeloaders, demands fee or flee

    Free incarnation of online app package, which became Workplace, is going away

    Google has served eviction notices to its legacy G Suite squatters: the free service will no longer be available in four months and existing users can either pay for a Google Workspace subscription or export their data and take their not particularly valuable businesses elsewhere.

    "If you have the G Suite legacy free edition, you need to upgrade to a paid Google Workspace subscription to keep your services," the company said in a recently revised support document. "The G Suite legacy free edition will no longer be available starting May 1, 2022."

    Continue reading
  • SpaceX Starlink sat streaks now present in nearly a fifth of all astronomical images snapped by Caltech telescope

    Annoying, maybe – but totally ruining this science, maybe not

    SpaceX’s Starlink satellites appear in about a fifth of all images snapped by the Zwicky Transient Facility (ZTF), a camera attached to the Samuel Oschin Telescope in California, which is used by astronomers to study supernovae, gamma ray bursts, asteroids, and suchlike.

    A study led by Przemek Mróz, a former postdoctoral scholar at the California Institute of Technology (Caltech) and now a researcher at the University of Warsaw in Poland, analysed the current and future effects of Starlink satellites on the ZTF. The telescope and camera are housed at the Palomar Observatory, which is operated by Caltech.

    The team of astronomers found 5,301 streaks leftover from the moving satellites in images taken by the instrument between November 2019 and September 2021, according to their paper on the subject, published in the Astrophysical Journal Letters this week.

    Continue reading
  • AI tool finds hundreds of genes related to human motor neuron disease

    Breakthrough could lead to development of drugs to target illness

    A machine-learning algorithm has helped scientists find 690 human genes associated with a higher risk of developing motor neuron disease, according to research published in Cell this week.

    Neuronal cells in the central nervous system and brain break down and die in people with motor neuron disease, like amyotrophic lateral sclerosis (ALS) more commonly known as Lou Gehrig's disease, named after the baseball player who developed it. They lose control over their bodies, and as the disease progresses patients become completely paralyzed. There is currently no verified cure for ALS.

    Motor neuron disease typically affects people in old age and its causes are unknown. Johnathan Cooper-Knock, a clinical lecturer at the University of Sheffield in England and leader of Project MinE, an ambitious effort to perform whole genome sequencing of ALS, believes that understanding how genes affect cellular function could help scientists develop new drugs to treat the disease.

    Continue reading

Biting the hand that feeds IT © 1998–2022